Open Access

Copy number changes and methylation patterns in an isodicentric and a ring chromosome of 15q11-q13: report of two cases and review of literature

  • Qin Wang1,
  • Weiqing Wu1, 2,
  • Zhiyong Xu1,
  • Fuwei Luo1,
  • Qinghua Zhou2, 3,
  • Peining Li2 and
  • Jiansheng Xie1Email author
Molecular Cytogenetics20158:97

https://doi.org/10.1186/s13039-015-0198-4

Received: 14 August 2015

Accepted: 10 November 2015

Published: 21 December 2015

Abstract

Background

The low copy repeats (LCRs) in chromosome 15q11-q13 have been recognized as breakpoints (BP) for not only intrachromosomal deletions and duplications but also small supernumerary marker chromosomes 15, sSMC(15)s, in the forms of isodicentric chromosome or small ring chromosome. Further characterization of copy number changes and methylation patterns in these sSMC(15)s could lead to better understanding of their phenotypic consequences.

Methods

Routine G-band karyotyping, fluorescence in situ hybridization (FISH), array comparative genomic hybridization (aCGH) analysis and methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) assay were performed on two Chinese patients with a sSMC(15).

Results

Patient 1 showed an isodicentric 15, idic(15)(q13), containing symmetrically two copies of a 7.7 Mb segment of the 15q11-q13 region by a BP3::BP3 fusion. Patient 2 showed a ring chromosome 15, r(15)(q13), with alternative one-copy and two-copy segments spanning a 12.3 Mb region. The defined methylation pattern indicated that the idic(15)(q13) and the r(15)(q13) were maternally derived.

Conclusions

Results from these two cases and other reported cases from literature indicated that combined karyotyping, aCGH and MS-MLPA analyses are effective to define the copy number changes and methylation patterns for sSMC(15)s in a clinical setting. The characterized genomic structure and epigenetic pattern of sSMC(15)s could lead to further gene expression profiling for better phenotype correlation.

Keywords

Isodicentric chromosomeRing chromosome15q11-q13Array comparative genomic hybridization (aCGH)Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA)

Background

The low copy repeats (LCRs) clustered in the chromosome 15q11-q13 region are known breakpoints 1 to 5 (BP1-5) for meiotic non-allelic homologous recombination which results in interstitial deletions and duplications [1]. Deletions of this region account for approximately 70 % of patients with Prader-Willi syndrome (PWS, OMIM#176270) and Angelman syndrome (AS, OMIM#105830). Reciprocal duplications of 15q11-q13 can cause autism, developmental delays, intellectual disability, ataxia, seizures, and behavioral problems (OMIM#608636). The PWS/AS critical region (PWACR) of 15q11-q13 contains many imprinting genes and shows the parental-origin effects [2]. In addition to intrachromosomal rearrangements, small supernumerary marker chromosomes 15, sSMC(15)s, in the forms of an inverted duplication (inv dup) or an isodicentric chromosome (idic) and a small ring chromosome, were also derived from rearrangements of the LCRs of 15q11-q13 [3]. The phenotypic consequences of these sSMC(15) are associated with their genomic structure, parental-origin imprinting effects and level of mosaicism [4].

Most sSMC(15)s take the form of a dicentric inv dup and can be classified into two groups: small sSMC(15)s and large sSMC(15)s. The small sSMC(15)s have breakpoints at the BP1 or BP2 proximal to the critical region and usually clinically irrelevant, while the large sSMC(15)s frequently extend beyond the BP3 to include the critical region and are frequently associated with abnormal phenotypes [517]. However, unexpected level of structural complexity including asymmetrical breakpoints, unequal size of inverted arms, and multiple types of atypical rearrangements among sSMC(15)s were noted [9, 12, 14, 15]. Previous studies showed that de novo sSMC(15)s characterized molecularly were of maternal origin [5, 7, 9, 10, 17]. It has been recognized that maternal duplication of this region will produce abnormal phenotype but paternal duplication carriers are commonly unaffected. However, recent studies showed that patients with paternal duplication of 15q11-q13 may also have mild abnormal phenotype [8, 17]. In addition to the genomic structure and parental origin, the level of mosaicism might also alter the risk associated with an abnormal phenotype. A mitigate effect correlating the mild phenotype of motor and speech development delay with the percentage and the type of cell lineages containing the sSMC(15) was suggested [10, 13, 15]. However, results from a large case series showed that about 60 % percent mosaic sSMC cases with clinical abnormalities had no direct correlation to the level of mosaicism in the peripheral blood and there is no simple relationship between clinical abnormalities and sSMC mosaicism [4].

The application of array comparative genomic hybridization (aCGH) analysis has proven very effective in defining the breakpoints, copy number changes, and gene content for sSMC(15)s [11, 12, 1417]. Recently, methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA), a rapid and cost-effective technique with high specificity and sensitivity, has been introduced for genetic analysis of copy number changes and methylation patterns [1821]. In this study, we present copy number changes and methylation pattern from an isodicentric chromosome 15 and a small ring chromosome 15. Review of literature found five reports with combined copy number and methylation analyses on 34 cases of sSMC(15)s and two cases of small ring chromosome 15 [17, 2225]. These results demonstrate that combined karyotype, FISH, aCGH and MS-MPLA analyses could be used in a clinical setting effectively to define genomic structure, parental origin and level of mosaicism for sSMC(15)s.

Results

Patient 1 is a 3-year-old girl. She was born at 41 weeks of gestation from an uneventful pregnancy and delivered by Caesarean section. Her birth weight was 3,550 g (75th percentile) and birth length was 51 cm (85th percentile). She showed head control at 6 months, standing with aid at 18 months, and walking not steadily at 26 months. Her verbal language was nearly absent and no visual contact. The daily life was completely taken care by the family. She showed no dysmorphic features and no record of seizures but was hypotonia and impulsive. She failed to follow instructions and lacked response to commands. Electroencephalography (EEG) study and nuclear magnetic resonance imaging (MRI) were normal. The parents were healthy and non-consanguineous. The father was 40-year-old and the mother was 42-year-old at the time of her birth. Parental chromosome studies were normal.

For patient 1, karyotyping analysis showed a supernumerary isodicentric chromosome 15, 47,XX,+idic(15)(pter → q13.1::q13.1 → pter), in all cells examined (Fig. 1a). FISH test was performed using dual color probes for the SNRPN gene at 15q11.2 and a control locus at 15qter. Of the 20 metaphase cells analyzed, the normal chromosomes 15 showed positive hybridization signals on the targeted loci from both probes and the idic(15) had two strong signals from the SNRPN probe but no signal from the control probe. Of the 50 interphases examined, four signals for the SNRPN probe and two signals for the control probe were noted (Fig. 1b). The result confirmed that the idic(15) contained two copies of the SNRPN gene region. The aCGH result indicated a 7.7 Mb duplication of chromosome 15q11-q13 (chr15:18,362,355-26,110,139) including genes from A26B1 to HERC2. The log2 ratio (L2R) was 0.885, indicating that the idic(15)(q13.1) was composed of two copies of the 15q11-q13 region with a breakage-fusion event occurred at BP3 (Fig. 1c). The MLPA result showed four copies for this chromosomal fragment by an increased mean peak height ratio of 2.0 (Fig. 1d). For the MS-MLPA in a normal control, the four probes for the SNRPN gene (a maternally methylated sequence containing a HhaI restriction site) decreased half of the peak height ratio, indicating the presence of one Hha I digested paternal unmethylated copy and another Hha I undigested maternal methylated copy. In patient 1, the MS-MLPA result showed a one-fourth decrease of the peak height ratio after Hha I digestion, indicating the presence of one copy unmethylated paternal SNRPN and three copies of methylated maternal SNRPN (Fig. 1e). These results indicated that the idic(15) was symmetric and of maternal origin.
Fig. 1

Karyotyping, FISH, aCGH and MS-MLPA results in patient 1. a. The chromosome image shows a normal pair of chromosome 15 and the extra idic(15). b. Metaphase and interphase FISH results show two copies of the SNRPN gene in the idic(15) (SNRPN red, 15qter green). c. The aCGH chromosome view (up) and gene view (bottom) reveal the breakpoint location and a 7.7 Mb duplication. d. The MS–MLPA pattern shows a peak height ratio value of 2 (four copies) in chromosome 15 (bottom) in comparison with a ratio value of 1 (two copies) from a normal control (upper). e. The MS-MLPA pattern indicates a methylation percentage of 0.75 in four SNRPN recognition sites in patient 1 (bottom) in comparison of 0.5 from a normal control (upper)

Patient 2 was a six-year-old girl. She was born at 39 weeks of gestation from an uneventful pregnancy and delivered by Caesarean section. She could sit without aid at age one year but walk clumsy and stumbled at 25 months. Her language ability was limited. She attended special educational training but made no much progress. She had intellectual disability, autistic like behaviors, hyperphagia and hyperactivity but no dysmorphic features. Sleep problem and epileptic seizure were not known in patient history. According to her parents, the girl could follow simple instructions and fetch small things. She could eat almost by herself but never achieved sphincter control. Her parents were healthy and they were 23-year-old at the time of her birth.

For patient 2, chromosome analysis performed on 100 metaphase cells from cultured peripheral blood lymphocytes showed a mosaic pattern for a supernumerary small ring chromosome 15, 47,XX,+r(15)(q13)[32]/46,XX[68] (Fig. 2a). The aCGH analysis revealed unique copy number changes in the 12.3 Mb region of 15q11-q13 (chr15:18,362,355-30,701,573) encompassing genes from A26B1 to CHRNA7. Starting from the proximal to the distal end at BP5, a 1.571 Mb tetrasomic segment of 15q11.1-q11.2 (chr15:18,362,355-19,934,192, L2R:1.000, proximal to BP1 with polymorphic copy number variants), a 2.404 Mb trisomic segment at 15q11.2 (chr15:20,418,129-22,821,963, L2R:0.360, from BP1 to between BP2/BP3), a 4.974 Mb tetrasomic segment of 15q11.2-q13.1 (chr15:23,020,445-27,994,906, L2R:0.727, from BP2/BP3 to BP3/BP4), followed by a 1.791 Mb trisomic segment (chr15: 28,910,278-30,701,573, L2R:0.350, from BP4 to BP5) were delineated (Fig. 2b). The MLPA result revealed an increased mean peak height ratio of 1.5 in segment from gene TUBGCP5 to SNRPN and a ratio of 2.0 in segment from UBE3A to APBA2. The results indicated that the r(15) had alternative two-copy and one-copy segments (Fig. 2c). The MS-MLPA result showed a one-fourth decrease of the peak height ratio after digestion, indicating that the duplication segment within the r(15) was methylated and of maternal origin (Fig. 2d).
Fig. 2

Karyotyping, aCGH and MS-MLPA results in patient 2. a. The chromosome image shows a normal pair of chromosome 15 and the extra r(15). b. The aCGH chromosome view (up) and gene view (bottom) reveal the breakpoint location and a 12.3 Mb. c. The MS-MLPA pattern shows peak height ratio value of 1.5 to 2.0 (three or four copies) in chromosome 15 (bottom) in comparison with a ratio value of 1 (two copies) from a normal control (upper). d. The MS-MLPA pattern indicates methylation aberration of 0.75 in four SNRPN recognition sites in patient 2 (bottom) in comparison with 0.5 from a normal control (upper)

Discussion and conclusion

Currently, more than 1300 similar sSMC(15) cases (published or not) are collected in the online sSMC database (http://ssmc-tl.com/sSMC.html). Carefully checking the website and review of literatures found five reports with combined karyotype, aCGH/SNP and methylation analyses on 34 cases of idic(15) and two cases of small r(15) [17, 2225]. The genomic structures and methylation patterns from these cases and our two cases are summarized in Table 1. For the formation of de novo idic(15), different types of breakage-fusion events including symmetrical BP3::BP3 and BP4::BP4 and asymmetric BP3::BP4, BP3::BP5 and BP4::BP5 were noted (Table 1). These observations indicated that the de novo idic(15)s originated from maternal meiotic crossing-over event between paired or mis-paired LCRS of homologous chromosomes in pachytene and followed by non-disjunction in the subsequent divisions [3]. Several modes of formation for inv dup or idic chromosome have been proposed. The most plausible mode of formation is the U-type exchange resulting from crossover mistakes of chromatids of two homologous chromosomes during meiosis [3] (Fig. 3a). Supernumerary small ring chromosome for the 15q11-q13 is an uncommon chromosomal abnormality and also likely derived from breakage and fusion event at the LCRs of 15q11-q13. However, the small r(15) from the two cases in the literature and our patient 2 showed break-fusions occurred between BPs (BP2/BP3 or BP3/BP4). The complex copy number changes and the variable breakage-fusion points within the r(15) may be explained by a two-step process including initial ring formation by a break-fusion event at the LCRs, an intermediate double ring from ring DNA replication, and a secondary asymmetric break-fusion event to introduce segmental duplications and deletions between BPs (Fig. 3b) [26, 27]. Therefore, for small supernumerary r(15), ring structure instability and secondary rearrangements should be considered.
Table 1

A summary of sSMC(15) defined by karyotype, aCGH or SNP, and methylation analyses

SMC15

Test Methods

Patient Number

Age

Gender

Inheritance

BP Fusion

Methylation

References

G-banding

aCGH/SNP

FISH

Methylation

trc(15), idic(15)

+

Nimblegen

+

MS-SB

2

11y, 26y

M, F

de novo

BP3::BP3, BP4::BP5

Maternal

[22] Hogart A, et al., 2009

rea(15), inv dup(15)

+

Affymetrix

+

MS-PCR

2

5y, 9y

M, M

de novo

BP4::BP5, BP4::BP5

Maternal

[23] Yang J, et al. 2013

inv dup(15) or idic(15)

+

Agilent & Illumina

+

MS-MLPA

8

1.7y-14.5y

M(3), F(5)

de novo

BP3::BP3,BP2-BP3::

Maternal

[17] Ageeli EA, et al. 2014

der(15)t(15q;6p)

    

1

7y

M

paternal carrier

BP2-BP3::

Paternal

 

del(15)[14]/psu dic(15)[4]

+

Agilent

+

MS-PCR

1

2y

F

de novo

BP3::BP3

Maternal

[24] Tan E-S, et al. 2014

idic(15)

+

Agilent

+

MS-MLPA

20

3 m-23y

M(13), F(7)

1 de novo, 19 unk

BP3::BP3 or BP4, BP4::BP4 or BP5

Maternal

[25] Aypar U, et al. 2014

idic(15)

+

Agilent

+

MS-MLPA

1

3y

F

de novo

BP3::BP3

Maternal

This report

r(15)

+

Agilent

+

MS-MLPA

2

1d, 7y

M, M

unk

BP2/BP3::,BP3::BP3

Maternal

[25] Aypar U, et al. 2014

r(15)

+

Agilent

-

MS-MLPA

1

6y

F

de novo

BP5::BP5> > BP2/BP3::BP3/BP4

Maternal

This report

Abbreviations: MS methylation sensitive, SB Southern blot; + = yes; − = not; m = month; y = year; unk, unknown

Fig. 3

Mechanisms for the idic(15) and ring 15. a. A schematic drawing shows the U-type exchange during meiosis for the formation of the idic(15) with a BP3::BP3 fusion. b. A schematic drawing shows the two-step process for the formation of r(15) from the initial ring formation with break-fusion at BP5, the formation of double ring through replication, and subsequent asymmetric breakage-fusion for segmental duplication and deletion (thin line for breakpoint, dash line for joining point)

Our two cases and almost all reported de novo cases of idic(15)s showed a genomic structure including PWACR and a methylation pattern of maternal origin [517, 2225]. As reported from previous analyses, clinical phenotypes for sSMC(15)s are related with the duplication region containing the PWACR and the maternally derived homologue of chromosome 15q [13, 17]. A comparison of clinical features between our patients and among those previously reported cases with similar size of duplication noted that patient 2 showed a relatively mild phenotype despite a larger size containing genes from BP1 to BP5. The presence of normal cells from the mosaic ring sSMC(15) might alleviate the severity of the clinical manifestation. Since routine karyotyping analysis was only done for cells from peripheral blood culture, the percentage of the mosaic r(15) in other tissues was not known. Micro-invasive methods to access other types of tissues, especially muscular and neurologic tissues, are needed to evaluate the mosaic pattern for sSMC(15)s. The gene content within sSMC(15)s and the parental-origin imprinting effects could be the determine factors affecting the phenotype [22, 28]. Patient 1 had a 7.7 Mb BP1-BP3 duplication which contains genes involving in developmental or neurological diseases. The BP1-BP2 region contains NIPA1, NIPA2 and CYFIP1 genes which are associated with the central nervous system development or function [2931]. The BP2-BP3 region contains paternally expressed genes MKRN3, MAGEL2, NDN and SNRPN; these four genes are implicated in the autism disorder [17, 32]. The maternally expressed UBE3A gene is exclusively-expressed in brain tissue and the neurodevelopmental complexities are associated with increased UBE3A in dup15q syndrome [33, 34]. The NDN gene is an imprinted gene expressed exclusively from the paternal allele, which is associated with neurological and muscular disorder and implicated as a negative growth regulator in human cancer [35, 36]. Patient 2 had a 12.3 Mb duplication involving BP1-BP5 region that extending to gene CHRNA7. The clinical phenotype like speech delay, hyperphagia, hyperactivity, mental retardation, no facial dysmorphism and no epilepsy may be influenced by gain of dosage of CHRNA7 [17, 37, 38]. In addition to the gene dosage effect, the gene expression may also contribute to the variability of the phenotypes which were influenced in unexpected ways through epigenetic changes [22]. Further elucidation of cellular functions and molecular pathways of the genes within the BP1-BP5 duplication region will facilitate better phenotype prediction and therapeutic intervention.

Several molecular methods including Southern blot analysis on methylation sensitive restriction sites, MS-PCR, sequencing of bisulfate-treated DNA, MS-PCR and MS-MLPA, have been introduced to define methylation pattern for sSMC(15)s [21, 22, 39]. Southern blot and sequencing methods are more time consuming and expensive. MS-PCR may show more variation in copy number quantitation. The present study and several reports have demonstrated that MS-MLPA is a robust, high-throughput, rapid and inexpensive approach with high specificity and sensitivity [2225]. It provides an efficient way to simultaneously detect copy number changes and DNA methylation within 15q11-q13 in a semi-quantitative manner [39]. Taken together, combined cell-based karyotyping and FISH to detect the chromosome structure and mosaic pattern with DNA-based aCGH and MS-MLPA for copy number changes and methylation patterns should be recommended for clinical analysis of sSMC(15). Practice guidelines for PWS/AS and analytic algorithms for sSMC(15)s using this combined methods have been proposed [25, 39].

In conclusion, we have defined the copy number changes and methylation pattern in an idic(15) and a r(15) from two Chinese patients by karyotyping, aCGH, and MS-MLPA analysis. The results revealed that the idic(15) with a BP3::BP3 fusion and a r(15) likely resulting from secondary breakage-fusion between BP2/BP3 and BP3/BP4 were maternally derived. Variable spectrum of neurodevelopmental phenotype might be explained by the gene dosage and epigenetic imprinting effects from these sSMC(15)s.

Methods

Patients

Two patients were referred for genetic evaluation of developmental delay, speech retardation and intellectual disabilities at the genetic counseling clinic in Shenzhen Maternal and Child Healthcare Hospital. This study was approved by the hospital’s Institutional Review Board and written informed consents were obtained from their parents.

Karyotype analysis

Chromosome analysis was performed on G-banded metaphases from cultured peripheral blood lymphocytes according to the laboratory’s standard protocols. An extended analysis of 100 G-banded metaphase cells was performed to allow the detection of equal or greater than 3 % of mosaicism with 95 % confidence interval [40].

FISH analysis

Fluorescence in situ hybridization (FISH) analysis was performed on metaphase chromosomes and interphase nuclei using dual color probes for the SNRPN gene at 15q11.2 and a control locus at 15qter (Cytocell Inc.) following the manufacturer’s instruction. Hybridization signal patterns were analyzed on twenty metaphase cells and 50 interphase cells. FISH probe preparation, in situ hybridization, signal scoring, and image capture were performed as previously described [41].

Array comparative genomic hybridization (aCGH)

Genomic DNA was extracted from the peripheral blood using the Gentra Puregene Blood kit (Qiangen, Valencia, CA, USA). DNA concentration was measured using a NanoDrop spectrophotometer (ND-1000, Thermo Fisher Scientific Inc., Waltham, Mass., USA), and DNA quality was verified by agarose gel electrophoresis. For each case, 2 ug of patient genomic DNA was used following the protocol from the SurePrint G3 Human CGH 8x60K Microarray Kit (Agilent Technologies, Santa Clara, CA, USA). DNA labeling, sex-matched test/control hybridization, post hybridization washes, image scanning, and data analysis were processed as previously described [39]. The base pair positions for detected genomic imbalances were designated according to the March 2006 Assembly (NCBI36/hg18) in the UCSC Human Genome browser (http://genome.ucsc.edu/).

MS-MLPA

MLPA reagents were obtained from MRC-Holland (Amsterdam, The Netherlands; SALSA MLPA kit ME028). The ME028 Kit can be used to detect copy number changes and to analyze the CpG island methylation of the 15q11 region in a semi-quantitative manner. The Kit contains 32 probes specific for sequences in the PWACR and 14 reference probes outside the region. Four of the PWACR specific probes in the SNRPN gene contain a recognition site for the methylation sensitive HhaI enzyme and can be used for the presence of aberrant methylation patterns in the 15q11 locus. The NDN gene also contains methylation probes while it has a known tendency to over-digest resulted in variable results. The experiment procedures were performed following the manufacturer’s protocol [18, 42]. The MS-MLPA data was imported into the software Coffalyser.Net (designed by MRC-Holland) to analyze both the copy number variation and the methylation profile.

Declarations

Acknowledgements

This work was supported by the National Natural Science Foundation of China (31471204). The authors appreciate the families to take part in this study. We also thank Audrey Meusel for checking and editing this manuscript.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Shenzhen Maternity and Child Healthcare Hospital
(2)
Department of Genetics, Yale School of Medicine
(3)
First Affiliated Hospital, Biomedical Translational Research Institute, Jinan University

References

  1. Zody MC, Garber M, Sharpe T, Young SK, Rowen L, O'Neill K, et al. Analysis of the DNA sequence and duplication history of human chromosome 15. Nature. 2006;440:671–5.PubMedView ArticleGoogle Scholar
  2. Horsthemke B, Buiting K. Imprinting defects on human chromosome 15. Cytogenet Genome Res. 2006;113:292–9.PubMedView ArticleGoogle Scholar
  3. Liehr T, Claussen U, Starke H. Small supernumerary marker chromosomes (sSMC) in humans. Cytogenet Genome Res. 2004;107:55–67.PubMedView ArticleGoogle Scholar
  4. Liehr T, Mrasek K, Weise A, Dufke A, Rodríguez L, Martínez Guardia N, et al. Small supernumerary marker chromosomes--progress towards a genotype-phenotype correlation. Cytogenet Genome Res. 2006;112:23–34.PubMedView ArticleGoogle Scholar
  5. Crolla JA, Harvey JF, Sitch FL, Dennis NR. Supernumerary marker 15 chromosomes: a clinical, molecular and FISH approach to diagnosis and prognosis. Hum Genet. 1995;95:161–70.PubMedView ArticleGoogle Scholar
  6. Huang B, Crolla JA, Christian SL, Wolf-Ledbetter ME, Macha ME, Papenhausen PN, et al. Refined molecular characterization of the breakpoints in small inv dup(15) chromosomes. Hum Genet. 1997;99:11–7.PubMedView ArticleGoogle Scholar
  7. Webb T, Hardy CA, King M, Watkiss E, Mitchell C, Cole T. A clinical, cytogenetic and molecular study of ten probands with supernumerary inv dup (15) marker chromosomes. Clin Genet. 1998;53:34–43.PubMedView ArticleGoogle Scholar
  8. Eggermann K, Mau UA, Bujdoso G, Koltai E, Engels H, Schubert R, et al. Supernumerary marker chromosomes derived from chromosome 15: analysis of 32 new cases. Clin Genet. 2002;62:89–93.PubMedView ArticleGoogle Scholar
  9. Roberts SE, Maggouta F, Thomas NS, Jacobs PA, Crolla JA. Molecular and fluorescence in situ hybridization characterization of the breakpoints in 46 large supernumerary marker 15 chromosomes reveals an unexpected level of complexity. Am J Hum Genet. 2003;73:1061–72.PubMedPubMed CentralView ArticleGoogle Scholar
  10. Maggouta F, Roberts SE, Dennis NR, Veltman MW, Crolla JA. A supernumerary marker chromosome 15 tetrasomic for the Prader-Willi/Angelman syndrome critical region in a patient with a severe phenotype. J Med Genet. 2003;40:e84.PubMedPubMed CentralView ArticleGoogle Scholar
  11. Locke DP, Segraves R, Nicholls RD, Schwartz S, Pinkel D, Albertson DG, et al. BAC microarray analysis of 15q11–q13 rearrangements and the impact of segmental duplications. J Med Genet. 2004;41:175–82.PubMedPubMed CentralView ArticleGoogle Scholar
  12. Wang NJ, Liu D, Parokonny AS, Schanen NC. High-resolution molecular characterization of 15q11-q13 rearrangements by array comparative genomic hybridization (Array CGH) with detection of gene dosage. Am J Hum Genet. 2004;75:267–81.PubMedPubMed CentralView ArticleGoogle Scholar
  13. Dennis NR, Veltman MWM, Thompson R, Crain E, Bolton PF, Thomas NS. Clinical findings in 33 subjects with large supernumerary marker(15) chromosomes and 3 subjects with triplication of 15q11-q13. Am J Med Genet. 2006;140:434–41.PubMedView ArticleGoogle Scholar
  14. Tsuchiya KD, Opheim KE, Hannibal MC, Hing AV, Glass IA, Raff ML, et al. Unexpected structural complexity of supernumerary marker chromosomes characterized by microarray comparative genomic hybridization. Mol Cytogenet. 2008;1:7.PubMedPubMed CentralView ArticleGoogle Scholar
  15. Wang NJ, Parokonny AS, Thatcher KN, Driscoll J, Malone BM, Dorrani N, et al. Multiple forms of atypical rearrangements generating supernumerary derivative chromosome 15. BMC Genet. 2008;9:2.PubMedPubMed CentralView ArticleGoogle Scholar
  16. Kleefstra T, de Leeuw N, Wolf R, Nillesen WM, Schobers G, Mieloo H, et al. Phenotypic spectrum of 20 novel patients with molecularly defined supernumerary marker chromosomes 15 and a review of the literature. Am J Med Genet. 2010;152A:2221–9.PubMedView ArticleGoogle Scholar
  17. Al Ageeli E, Drunat S, Delanoë C, Perrin L, Baumann C, Capri Y, et al. Duplication of the 15q11-q13 region: clinical and genetic study of 30 new cases. Eur J Med Genet. 2014;57:5–14.PubMedView ArticleGoogle Scholar
  18. Nygren AO, Ameziane N, Duarte HM, Vijzelaar RN, Waisfisz Q, Hess CJ, et al. Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences. Nucleic Acids Res. 2005;33:e128.PubMedPubMed CentralView ArticleGoogle Scholar
  19. Procter M, Chou LS, Tang W, Jama M, Mao R. Molecular diagnosis of Prader-Willi and Angelman syndromes by methylation-specific melting analysis and methylation-specific multiplex ligation-dependent probe amplification. Clin Chem. 2006;52:1276–83.PubMedView ArticleGoogle Scholar
  20. Bittel DC, Kibiryeva N, Butler MG. Methylation-specific multiplex ligation-dependent probe amplification analysis of subjects with chromosome 15 abnormalities. Genet Test. 2007;11:467–75.PubMedView ArticleGoogle Scholar
  21. Depienne C, Moreno-De-Luca D, Heron D, Bouteiller D, Gennetier A, Delorme R, et al. Screening for genomic rearrangements and methylation abnormalities of the 15q11-q13 region in autism spectrum disorders. Biol Psychiatry. 2009;66:349–59.PubMedView ArticleGoogle Scholar
  22. Hogart A, Leung KN, Wang NJ, Wu DJ, Driscoll J, Vallero RO, et al. Chromosome 15q11-13 duplication syndrome brain reveals epigenetic alterations in gene expression not predicted from copy number. J Med Genet. 2009;46:86–93.PubMedPubMed CentralView ArticleGoogle Scholar
  23. Yang J, Yang Y, Huang Y, Hu Y, Chen X, Sun H, et al. A study of two Chinese patients with tetrasomy and pentasomy 15q11q13 including Prader-Willi/Angelman syndrome critical region present with developmental delays and mental impairment. BMC Med Genet. 2013;14:9.PubMedPubMed CentralView ArticleGoogle Scholar
  24. Tan ES, Yong MH, Lim EC, Li ZH, Brett MS, Tan EC. Chromosome 15q11-q13 copy number gain detected by array-CGH in two cases with a maternal methylation pattern. Mol Cytogenet. 2014;7:32.PubMedPubMed CentralView ArticleGoogle Scholar
  25. Aypar U, Brodersen PR, Lundquist PA, Dawson DB, Thorland EC, Hoppman N. Does parent of origin matter? Methylation studies should be performed on patients with multiple copies of the Prader-Willi/Angelman syndrome critical region. Am J Med Genet. 2014;164A:2514–20.PubMedView ArticleGoogle Scholar
  26. Sodre CP, Guilherme RS, Meloni VF, Brunoni D, Juliano Y, Andrade JA, et al. Ring chromosome instability evaluation in six patients with autosomal rings. Genet Mol Res. 2010;9:134–43.PubMedView ArticleGoogle Scholar
  27. Zhang HZ, Xu F, Seashore M, Li P. Unique genomic structure and distinct mitotic behavior of ring chromosome 21 in two unrelated cases. Cytogenet Genome Res. 2012;136:180–7.PubMedView ArticleGoogle Scholar
  28. Burnside RD, Pasion R, Mikhail FM, Carroll AJ, Robin NH, Youngs EL, et al. Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet. 2011;130:517–28.PubMedView ArticleGoogle Scholar
  29. Goytain A, Hines RM, El-Husseini A, Quamme GA. NIPA1(SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter. J Biol Chem. 2007;282:8060–8.PubMedView ArticleGoogle Scholar
  30. Goytain A, Hines RM, Quamme GA. Functional characterization of NIPA2, a selective Mg2+ transporter. Am J Physiol Cell Physiol. 2008;295:944–53.View ArticleGoogle Scholar
  31. Napoli I, Mercaldo V, Boyl PP, Eleuteri B, Zalfa F, De Rubeis S, et al. The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP. Cell. 2008;134:1042–54.PubMedView ArticleGoogle Scholar
  32. Chamberlain SJ, Lalande M. Neurodevelopmental disorders involving genomic imprinting at human chromosome 15q11-q13. Neurobiol Dis. 2010;39:13–20.PubMedView ArticleGoogle Scholar
  33. Scoles HA, Urraca N, Chadwick SW, Reiter LT, Lasalle JM. Increased copy number for methylated maternal 15q duplications leads to changes in gene and protein expression in human cortical samples. Mol Autism. 2011;2:19.PubMedPubMed CentralView ArticleGoogle Scholar
  34. Smith SE, Zhou YD, Zhang G, Jin Z, Stoppel DC, Anderson MP. Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. Sci Transl Med. 2011;3:103ra97.PubMedPubMed CentralGoogle Scholar
  35. Jay P, Rougeulle C, Massacrier A, Moncla A, Mattei MG, Malzac P, et al. The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region. Nat Genet. 1997;17:357–61.PubMedView ArticleGoogle Scholar
  36. Haviland R, Eschrich S, Bloom G, Ma Y, Minton S, Jove R, et al. Necdin, a negative growth regulator, is a novel STAT3 target gene down-regulated in human cancer. PLoS One. 2011;6:e24923.PubMedPubMed CentralView ArticleGoogle Scholar
  37. Gault J, Robinson M, Berger R, Drebing C, Logel J, Hopkins J, et al. Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics. 1998;52(2):173–85.PubMedView ArticleGoogle Scholar
  38. Xu J, Pato MT, Torre CD, Medeiros H, Carvalho C, Basile VS, et al. Evidence for linkage disequilibrium between the alpha 7-nicotinic receptor gene (CHRNA7) locus and schizophrenia in Azorean families. Am J Med Genet. 2001;105:669–74.PubMedView ArticleGoogle Scholar
  39. Ramsden SC, Clayton-Smith J, Birch R, Buiting K. Practice guidelines for the molecular analysis of Prader Willi and Angelman syndromes. BMC Med Genet. 2010;11:70.PubMedPubMed CentralView ArticleGoogle Scholar
  40. Hook EB. Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use. Am J Hum Genet. 1977;29:94–7.PubMedPubMed CentralGoogle Scholar
  41. Zhang HZ, Li P, Wang D, Huff S, Nimmakayalu M, Qumsiyeh M, et al. FOXC1 gene deletion is associated with eye anomalies in ring chromosome 6. Am J Med Genet A. 2004;124a(3):280–7.PubMedView ArticleGoogle Scholar
  42. Xu ZY, Geng Q, Luo FW, Xu F, Li P, Xie JS. Multiplex ligation-dependent probe amplification and array comparative genomic hybridization analyses for prenatal diagnosis of cytogenomic abnormalities. Mol Cytogenet. 2014;7:84.PubMedPubMed CentralView ArticleGoogle Scholar

Copyright

© Wang et al. 2015

Advertisement